Consequently, whether targeting the intracellular K+ homeostasis represents feasible 1) to target cancer cell proliferation and 2) to specifically affect (cancer) cell metabolism by targeting HKII or also via modulating the activity of other enzymes remains elusive but might be aim of future studies. This evidence concerns the gene HK2 and cancer.